• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Glu (c.394A>G); ClinVar=VCV000376626; Zygosity=Unspecified (from parent cell line).
  

PubMed=2846161
Geke A.P. Hospers, Nanno H. Mulder, Bauke de Jong, Lou F.M.H. de Leij, Donald Robert Alexander Uges, Anne Marie Josephine Fichtinger-Schepman, Riekeld J. Scheper, Elisabeth Geertruida Emma de Vries;
Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.
Cancer Res. 48:6803-6807(1988)

PubMed=2163989; DOI=10.1002/ijc.2910460125
Geke A.P. Hospers, Coby Meijer, Lou F.M.H. de Leij, Donald Robert Alexander Uges, Nanno H. Mulder, Elisabeth Geertruida Emma de Vries;
A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance.
Int. J. Cancer 46:138-144(1990)

PubMed=1657425; DOI=10.1007/BF00685823
Steven de Jong, Jan G. Zijlstra, Nanno H. Mulder, Elisabeth Geertruida Emma de Vries;
Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance.
Cancer Chemother. Pharmacol. 28:461-464(1991)

PubMed=12093475; DOI=10.1016/S0006-2952(02)00983-8
Eelco Fokkema, Harry J.M. Groen, Marco N. Helder, Elisabeth Geertruida Emma de Vries, Coby Meijer;
JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatin.
Biochem. Pharmacol. 63:1989-1996(2002)

PubMed=20615970; DOI=10.1073/pnas.1008132107; PMCID=PMC2919980
Johannes Voortman, Jih-Hsiang Lee, Jonathan Keith Killian, Miia Suuriniemi, Yong-Hong Wang, Marco Lucchi, William I. Smith Jr., Paul S. Meltzer, Yi-Song Wang, Giuseppe Giaccone;
Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors.
Proc. Natl. Acad. Sci. U.S.A. 107:13040-13045(2010)